Sobi KOL investor event: Advancing the standard of care in haemophilia
18 September 2023 15:00 CEST, 14:00 BST, 09:00 EDT Sobi invites investors to participate in a virtual KOL haemophilia event on 18 September 2023 at 15:00 CEST. Guido Oelkers, Chief Executive Officer, Lydia Abad-Franch, MD, MBA, acting Chief Medical Officer, and Key Opinion Leader, Robert Klamroth, MD, PhD, Chief Physician, Clinic for Internal Medicine – Angiology and Hemostaseology, Vivantes, Berlin, Germany, will discuss Sobi’s haemophilia portfolio with a particular focus on efanesoctocog alfa. The presentation can be followed live here